[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367883-105":59,"doc-detail-367883-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","head-and-neck-malignancies-in-autoimmune-polyendocrine-syndrome-type-1-aps-1apeced-a-scoping-review-of-molecular-pathogenesis-clinical-features-and-outcomes","Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED) - A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes","","Autoimmune polyendocrine syndrome type 1 (APS-1, APECED) is a rare monogenic disorder caused by biallelic AIRE mutations and classically presents with chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency. Beyond autoimmunity, APS-1 increases the risk of squamous cell carcinoma, especially in the oral cavity and esophagus. A scoping review following PRISMA-ScR searched Pub-Med, Scopus, and Web of Science up to July 2025, summarizing molecular, clinical, pathological, and outcome evidence from eligible histologically confirmed cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/head-and-neck-malignancies-in-autoimmune-polyendocrine-syndrome-type-1-aps-1apeced-a-scoping-review-of-molecular-pathogenesis-clinical-features-and-outcomes/367883/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/head-and-neck-malignancies-in-autoimmune-polyendocrine-syndrome-type-1-aps-1apeced-a-scoping-review-of-molecular-pathogenesis-clinical-features-and-outcomes/367883.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is APS-1/APECED, and why is it clinically significant for malignancy risk?","Question",{"text":112,"@type":113},"APS-1/APECED is a rare monogenic disorder due to biallelic AIRE mutations. It is classically associated with chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency, and it also increases the risk of squamous cell carcinoma, particularly in the oral cavity and esophagus.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the scoping review conducted?",{"text":117,"@type":113},"The review followed PRISMA-ScR guidelines and searched Pub-Med, Scopus, and Web of Science using terms APS-1/APECED and malignancy until July 2025. Eligible studies reported histologically confirmed head, neck, or esophageal cancers in APS-1 patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes and tumor characteristics were most frequently reported?",{"text":121,"@type":113},"Across included reports, most tumors were squamous cell carcinoma, with tumors occurring most frequently in the oral cavity. Outcomes were poor overall, with high recurrence and mortality rates despite multimodal treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367883,1790459670,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nHead and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes  \nMarko Tarle 1,2,†, Marina Raguž 3,4,† and Ivica Lukši´c 1,5, *  \nAcademic Editor:  \nAntonio Arnaiz-Villena  \nReceived: 30 August 2025  \nRevised: 7 September 2025  \nAccepted: 13 September 2025  \nPublished: 15 September 2025  \nCitation: Tarle, M.; Raguž, M.; Lukši´c, I. Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED):  \nAScoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes. Int. J. Mol. Sci. 2025, 26, 8969. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26188969  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia; [tarlemarko1@gmail.com](tarlemarko1@gmail.com)  \n2 School of Dental Medicine, University of Zagreb, Gunduli´ceva 5, 10000 Zagreb, Croatia  \n3 Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia; [marinaraguz@gmail.com](marinaraguz@gmail.com)  \n4 School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia  \n5 School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia  \n* Correspondence: [luksic@kbd.hr](luksic@kbd.hr)  \n† These authors contributed equally to this work.  \nAbstract  \nAutoimmune polyendocrine syndrome type 1 (APS-1, APECED) is a rare monogenic disorder caused by biallelic AIRE mutations and is classically associated with chronic mucocutaneous candidiasis (CMC), hypoparathyroidism, and adrenal insufficiency. Apart from the autoimmune manifestations, APS-1 is associated with an increased risk of squamous cell carcinoma (SCC), particularly in the oral cavity and esophagus. However, the evidence is patchy and has not yet been systematically reviewed. We conducted a scoping review according to the PRISMA-ScR guidelines. Pub-Med, Scopus, and Web of Science were searched using the terms APS-1/APECED and malignancy until July 2025 . Eligible studies reported on APS-1 patients with histologically confirmed head, neck or esophageal cancer. Clinical, pathological, genetic and outcome data were summarized narratively. Nine publications described 19 APS-1 patients with 26 tumors. The mean age at cancer diagnosis was 35 years, with a latency period of ~24 years from the onset of APS-1 . Tumors occurred most frequently in the oral cavity (65%), followed by the lip (19%) and esophagus (15%) . In 96% of cases, the tumors were SCC. The grade of the tumor varied, and almost half of the cases were diagnosed at an advanced stage. As far as reported, the usual risk factors were not particularly pronounced; many patients did not smoke or drink alcohol. The main treatment consisted of surgery, often in combination with radiotherapy or chemoradiotherapy, alongside long-term antifungal therapy. Despite the multimodal treatment, outcomes were poor: the overall survival rate was ~50%, with recurrence occurring in 38% of cases and a second primary tumor in 26% . A further 14 cases were reported from another Italian cohort, which together with the national cohort dana suggest a risk of approximately ~10% with APS-1; however, the true lifetime risk remains uncertain. Head and neck malignancies in APS-1 occur early, often without classic risk factors, and have a high recurrence and mortality rate. Lifelong surveillance, antifungal stewardship and increased clinical awareness, ideally as part of multidisciplinary treatment pathways, are critical to improving outcomes in this rare but high-risk population.  \nKeywords: autoimmune polyendocrine syndr","cbCainDBHPHiFYkT","https://ap.wps.com/l/cbCainDBHPHiFYkT","pdf",1309948,23,"English","# Abstract\n## Background\n## Methods and Evidence Base\n## Findings and Clinical Implications","[{\"question\":\"What is APS-1/APECED, and why is it clinically significant for malignancy risk?\",\"answer\":\"APS-1/APECED is a rare monogenic disorder due to biallelic AIRE mutations. It is classically associated with chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency, and it also increases the risk of squamous cell carcinoma, particularly in the oral cavity and esophagus.\"},{\"question\":\"How was the scoping review conducted?\",\"answer\":\"The review followed PRISMA-ScR guidelines and searched Pub-Med, Scopus, and Web of Science using terms APS-1/APECED and malignancy until July 2025. Eligible studies reported histologically confirmed head, neck, or esophageal cancers in APS-1 patients.\"},{\"question\":\"What outcomes and tumor characteristics were most frequently reported?\",\"answer\":\"Across included reports, most tumors were squamous cell carcinoma, with tumors occurring most frequently in the oral cavity. Outcomes were poor overall, with high recurrence and mortality rates despite multimodal treatment.\"}]","Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED) - A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes | PDF",1790173162,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e529a96facfe6a4b49fec2d672a8eeff.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6d2283d015a4f5e173261839152969d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f17fa5b5d423aa675d91a03ac8c8ec23.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41f8b9c0d8d973192b87fdbdf981d86d.webp",980,1385]